| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Qian Xiao | Q91678385 |
| Yu Zhai | Q95947055 | ||
| P2093 | author name string | Qian Xiao | |
| Yu Zhai | |||
| P2860 | cites work | Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study | Q87345282 |
| Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis | Q47990669 | ||
| Sarcopenia: origins and clinical relevance | Q48615717 | ||
| Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism. | Q50504013 | ||
| No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. | Q51250755 | ||
| Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1. | Q51544078 | ||
| Association between visceral obesity and sarcopenia and vitamin D deficiency in older Koreans: the Ansan Geriatric Study. | Q53388391 | ||
| Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. | Q54610580 | ||
| Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia. | Q54721642 | ||
| Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011) | Q57220867 | ||
| Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans | Q80471118 | ||
| Shedding new light on vitamin D and fatty liver disease | Q83208695 | ||
| Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation | Q85084971 | ||
| Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People | Q24633789 | ||
| Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective | Q28278787 | ||
| Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994 | Q28384968 | ||
| Insulin resistance of muscle protein metabolism in aging | Q33584429 | ||
| Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity | Q33633052 | ||
| ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. | Q33636677 | ||
| Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism. | Q33745051 | ||
| Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes | Q33958775 | ||
| Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. | Q34197477 | ||
| Multi-step immunofluorescent analysis of vitamin D receptor loci and myosin heavy chain isoforms in human skeletal muscle | Q34216794 | ||
| Meta-analysis: vitamin D and non-alcoholic fatty liver disease | Q34352252 | ||
| Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam | Q34543875 | ||
| 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells | Q35110817 | ||
| Adiponectin and its receptors in non-alcoholic steatohepatitis. | Q35597147 | ||
| Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. | Q35681550 | ||
| Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects | Q35888143 | ||
| Insulin resistance: a contributing factor to age-related muscle mass loss? | Q36369782 | ||
| Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice | Q36479005 | ||
| Review: The role of insulin resistance in nonalcoholic fatty liver disease | Q36591903 | ||
| Vitamin D and health: perspectives from mice and man. | Q37149442 | ||
| Causes and metabolic consequences of Fatty liver | Q37250791 | ||
| Vitamin D and skeletal muscle tissue and function | Q37252547 | ||
| Insulin resistance, inflammation, and non-alcoholic fatty liver disease | Q37301920 | ||
| Aerobic exercise overcomes the age-related insulin resistance of muscle protein metabolism by improving endothelial function and Akt/mammalian target of rapamycin signaling | Q37339750 | ||
| Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review. | Q37675499 | ||
| Obesity affects the liver - the link between adipocytes and hepatocytes. | Q37806012 | ||
| Chronic low-grade inflammation and age-related sarcopenia. | Q37959664 | ||
| Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction | Q37967213 | ||
| Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver | Q38034704 | ||
| Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis | Q38592508 | ||
| Active vitamin D possesses beneficial effects on the interaction between muscle and bone | Q38985381 | ||
| A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults | Q39110884 | ||
| Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey. | Q40051906 | ||
| The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes | Q40505909 | ||
| Is the adiponectin-AMPK-mitochondrial axis involved in progression of nonalcoholic fatty liver disease? | Q42399283 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| sarcopenia | Q1787939 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 6297651 | |
| P577 | publication date | 2017-12-13 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | The Common Mechanisms of Sarcopenia and NAFLD. | |
| P478 | volume | 2017 |
| Q64092616 | Building mass to prevent non-alcoholic fatty liver disease? |
| Q99610098 | Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease |
| Q95641898 | Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011) |
| Q64092690 | Sarcopenia and nonalcoholic fatty liver disease: a causal relationship |
| Q92223928 | Skeletal muscle mass and sarcopenia in nonalcoholic fatty liver disease |
| Q57066878 | The Association between Nonalcoholic Fatty Liver Disease and CT-Measured Skeletal Muscle Mass |
Search more.